Preference for long-acting injectable PrEP compared to daily oral PrEP among transgender women in the United States: Findings from a multi-site cohort

•Transgender women prefer long-acting injectable PrEP to daily oral PrEP (58% to 42%)•Trans women with current PrEP indications are more likely to prefer long-acting PrEP•Trans women who have injected hormones are more likely to prefer long-acting PrEP•Increasing access to long-acting PrEP may improve PrEP uptake in trans women